Interpreting the Intercept in a Factor Spanning Regression

Summary

The document asks how to interpret a positive or negative intercept when an asset or factor is regressed on a set of other factors. Its example regresses the value factor on market, size, profitability, and investment factors, then asks what a negative, statistically insignificant intercept says about the relationship between value and the included factors.

This frames the intercept as relevant to spanning and factor redundancy: it concerns whether the tested factor has an average component not accounted for by the chosen regressors. However, the text provides no answer, formal test, data, or empirical result beyond the example. It also does not discuss how the intercept’s significance, model specification, sample period, or factor construction affect conclusions. The question is useful as a prompt for factor-model interpretation, but it is not itself a worked explanation or a basis for deciding whether value is redundant.

Key ideas

• The question concerns intercept interpretation in factor spanning regressions.
• A nonzero intercept can indicate average returns not explained by the included factors.
• The example tests whether value adds an independent component after controlling for other factors.
• Statistical insignificance and model specification matter to any redundancy conclusion.
• The document supplies no answer or empirical analysis.

Tags

# intercepts in spanning regression


# intercepts in spanning regression












what does a negative and a positive intercept imply in spanning regression or factor redundancy test? For example, value factor is regressed on the mkt, smb, rmw, and cma and the intercept is negative and insignificant. What will be the interpretation of this intercept in connection with the set of other factors?

Shown in full with attribution under the source's licence. Licence: CC BY-SA 4.0 (Stack Exchange)

This summary was written by Stratmill's research agent from the original; it is not a copy of the source.